References
- Beam W, Borckardt JJ, Reeves ST, George MS. 2009. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul. 2(1):50–54.
- Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, Smeraldi E. 2005. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry. 66(12):1535–1540.
- Benedetti F, Riccaboni R, Locatelli C, Poletti S, Dallaspezia S, Colombo C. 2014. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression. J Clin Psychiatry. 75(02):133–140.
- Connolly KR, Helmer A, Cristancho MA, Cristancho P, O'Reardon JP. 2012. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry. 73(4):e567–e573.
- Hoogendam JM, Ramakers GM, Di Lazzaro V. 2010. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 3(2):95–118.
- Kragh M, Larsen ER, Martiny K, Møller DN, Wihlborg CS, Lindhardt T, Videbech P. 2018. Predictors of response to combined wake and light therapy in treatment-resistant inpatients with depression. Chronobiol Int. 35(9):1209–1220.
- Kripke DF, Mullaney DJ, Klauber MR, Risch SC, Gillin JC. 1992. Controlled trial of bright light for nonseasonal major depressive disorders. Biol Psychiatry. 31(2):119–134.
- Lavretsky H, Reinlieb M, St Cyr N, Siddarth P, Ercoli LM, Senturk D. 2015. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 172(6):561–569.
- Lucca A, Rossini D, Malaguti A, Zanardi R, Magri L, Smeraldi E. 2010. Use of electroconvulsive therapy in the city of Milan: a naturalistic study. J ECT. 26(2):148.
- Mania I, Kaur J. 2019. Bright Light Therapy and rTMS; novel combination approach for the treatment of depression. Brain Stimul. 12(5):1338–1339.
- McCloud TL, Caddy C, Jochim J, Rendell JM, Diamond PR, Shuttleworth C, Brett D, Amit BH, McShane R, Hamadi L, et al. 2015. Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev. (9):CD011612.
- Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS, et al. 2016. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul. 9(2):251–257.
- Pilon D, Joshi K, Sheehan J, Zichlin M, Zuckerman P, Lefebvre P, Greenberg P. 2019. Burden of treatment-resistant depression in Medicare: a retrospective claims database analysis. PLoS One. 14(10):e0223255.
- Thase ME, Rush AJ. 1997. When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 58(Suppl 13):23–29.